TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/21 19:00 | 3/9/21 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Worboys Philip D | CA | O | SVP,Rese | S | -177 | 20.00 | 0 | -9 | -3 | 344 | D | ||||||||||||||
12/7/20 18:42 | 12/3/20 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Worboys Philip D | CA | O | SVP,Rese | S | -76 | 18.00 | 0 | -4 | -1 | 319 | D | ||||||||||||||
8/24/20 18:38 | 8/20/20 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Worboys Philip D | CA | O | SVP,Rese | S | -308 | 18.00 | 0 | -17 | -5 | 328 | D | ||||||||||||||
9/14/18 17:03 | 9/12/18 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Worboys Philip D | CA | O | SVP,Tran | S | -182 | 28.50 | 0 | -6 | -4 | 167 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |